In utero tobacco exposure epigenetically modifies placental CYP1A1 expression.
The metabolic pathways used by higher-eukaryotic organisms to deal with potentially carcinogenic xenobiotic compounds from tobacco smoke have been well characterized. Carcinogenic compounds such as polycyclic aromatic hydrocarbons are metabolized sequentially in 2 phases: in phase I, CYP1A1 catalyzes conversion into harmful hydrophilic DNA adducts, whereas in phase II, GSTT1 enables excretion via conjugation into polar electrophiles. In an effort to understand susceptibility to in utero tobacco exposure, we previously characterized known metabolic functional polymorphisms and demonstrated that although deletion of fetal GSTT1 significantly modified birth weight in smokers, no polymorphism fully accounted for fetal growth restriction. Because smoking up-regulates CYP1A1 expression, we hypothesized that nonallelic (epigenetic) dysregulation of placental CYP1A1 expression via alterations in DNA methylation (meCpG) may further modify fetal growth. In the present article, we compared placental expression of multiple CYP family members among gravidae and observed significantly increased CYP1A1 expression among smokers relative to controls (4.4-fold, P < .05). To fully characterize CYP1A1 meCpG status, bisulfite modification and sequencing of the entire proximal 1-kilobase promoter (containing 59 CpG sites) were performed. CpG sites immediately proximal to the 5′-xenobiotic response element transcription factor binding element were significantly hypomethylated among smokers (55.6% vs 45.9% meCpG, P = .027), a finding that uniquely correlated with placental gene expression (r = 0.737, P = .007). Thus, in utero tobacco exposure significantly increases placental CYP1A1 expression in association with differential methylation at a critical xenobiotic response element.
Suter
Melissa
M
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Abramovici
Adi
A
Showalter
Lori
L
Hu
Min
M
Shope
Cynthia Do
CD
Varner
Michael
M
Aagaard-Tillery
Kjersti
K
D000328:Adult; D001724:Birth Weight / Q000187:drug effects / Q000502:physiology; D016022:Case-Control Studies; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation / Q000235:genetics; D044127:Epigenesis, Genetic / Q000187:drug effects; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007231:Infant, Newborn; D018811:Maternal Exposure / Q000009:adverse effects; D008431:Maternal-Fetal Exchange / Q000235:genetics*; D010920:Placenta / Q000201:enzymology / Q000378:metabolism*; D011247:Pregnancy; D011401:Promoter Regions, Genetic; D012906:Smoke; D012907:Smoking / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology
D012906:Smoke; D019363:Cytochrome P-450 CYP1A1
Pediatr Int. 2010 Feb;52(1):94-9
19400912
Arch Toxicol. 2005 Jan;79(1):13-24
15448981
Carcinogenesis. 2006 Mar;27(3):525-32
16195240
Clin Pharmacol Ther. 2008 Apr;83(4):542-50
17928820
J Nutr. 2009 Jun;139(6):1054-60
19339705
Early Hum Dev. 2007 Nov;83(11):699-706
17900829
Nicotine Tob Res. 2004 Apr;6 Suppl 2:S125-40
15203816
Carcinogenesis. 2002 Dec;23(12):1969-77
12507920
Exp Toxicol Pathol. 1999 Jul;51(4-5):412-7
10445407
Nat Cell Biol. 2008 Jan;10(1):102-9
18066050
Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):581-8
11401906
Int J Cancer. 2004 Jun 10;110(2):266-70
15069692
Am J Obstet Gynecol. 2005 May;192(5 Suppl):S11-21
15891707
Cancer Res. 2003 Dec 15;63(24):8623-8
14695173
J Clin Invest. 2007 Dec;117(12):3971-8
18037991
Int J Epidemiol. 1998 Aug;27(4):647-56
9758120
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17046-9
18955703
Nat Rev Cancer. 2006 Dec;6(12):947-60
17128211
Environ Health Perspect. 2006 Nov;114(11):1744-50
17107862
Hum Exp Toxicol. 2000 Nov;19(11):597-603
11211237
Pediatr Dev Pathol. 2004 Sep-Oct;7(5):433-42
15568214
Addict Behav. 2003 Jan-Feb;28(1):55-66
12507527
Curr Opin Plant Biol. 2008 Oct;11(5):554-9
18774331
Br J Clin Pharmacol. 2001 Oct;52(4):357-63
11678779
Am J Obstet Gynecol. 1957 Apr;73(4):807-15
13411046
Am J Clin Nutr. 2009 Feb;89(2):673S-7S
19116320
Environ Health Perspect. 2007 Oct;115(10):1497-502
17938742
Curr Biol. 2007 Dec 4;17(23):2041-6
17997309
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):405-13
18268125
Am J Obstet Gynecol. 2008 Jan;198(1):66.e1-6
18166310
Environ Health Perspect. 1999 Jun;107 Suppl 3:451-60
10346993
Carcinogenesis. 2005 Jun;26(6):1122-8
15731166
Carcinogenesis. 2007 Sep;28(9):1902-5
17307802
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):207-12
10698483
Allergy. 2009 Mar;64(3):445-51
19170671
Addict Behav. 2005 May;30(4):853-7
15833588
Curr Issues Mol Biol. 2008;10(1-2):25-36
18525104
Int J Obes (Lond). 2008 Sep;32(9):1373-9
18626486
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13056-61
17670942
J Cancer Res Clin Oncol. 1997;123(3):141-51
9119879
Am J Obstet Gynecol. 1990 Jan;162(1):53-8
2301517
Environ Res. 1989 Oct;50(1):173-83
2792058
JAMA. 2002 Jan 9;287(2):195-202
11779261
Br J Nutr. 2007 Mar;97(3):435-9
17313703
J Natl Cancer Inst. 1988 Jun 15;80(8):567-76
3373547
Nicotine Tob Res. 2007 Oct;9(10):1005-13
17852766
Methods. 2001 Dec;25(4):402-8
11846609
Am J Public Health. 1997 Mar;87(3):410-3
9096542
Paediatr Perinat Epidemiol. 2001 Apr;15(2):140-3
11383579
Br J Nutr. 2008 Mar;99(3):540-9
17761015